# Relmada Therapeutics, Inc.: Form SC 13D/A, filed Dec 7, 2015

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: SC 13D/A
- Filed: 2015-12-07
- Accepted by EDGAR: Dec 4, 2015, 21:56 ET
- Period: not reported
- Accession: 0001144204-15-069493
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000114420415069493/v426288_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000114420415069493/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000114420415069493/v426288_sc13da.htm

Filed Dec 7, 2015.
Source: SEC EDGAR, the filing index for accession 0001144204-15-069493. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
